292 related articles for article (PubMed ID: 26035012)
1. Biobank classification in an Australian setting.
Rush A; Christiansen JH; Farrell JP; Goode SM; Scott RJ; Spring KJ; Byrne JA
Biopreserv Biobank; 2015 Jun; 13(3):212-8. PubMed ID: 26035012
[TBL] [Abstract][Full Text] [Related]
2. An Australian Biobank Certification Scheme: A Study of Economic Costs to Participating Biobanks.
Ling R; Rush A; Carter C; Carpenter J; Watson PH; Byrne JA; Searles A
Biopreserv Biobank; 2018 Feb; 16(1):53-58. PubMed ID: 29215912
[TBL] [Abstract][Full Text] [Related]
3. Quality and reporting practices in an Australian cancer biobank cohort.
Rush A; Byrne JA
Clin Biochem; 2016 Apr; 49(6):492-497. PubMed ID: 26708174
[TBL] [Abstract][Full Text] [Related]
4. Inter- and intra-biobank networks: classification of biobanks.
Shickle D; Griffin M; El-Arifi K
Pathobiology; 2010; 77(4):181-90. PubMed ID: 20616613
[TBL] [Abstract][Full Text] [Related]
5. Biospecimen User Fees: Global Feedback on a Calculator Tool.
Matzke LA; Babinszky S; Slotty A; Meredith A; Castillo-Pelayo T; Henderson MK; Simeon-Dubach D; Schacter B; Watson PH
Biopreserv Biobank; 2017 Feb; 15(1):57-64. PubMed ID: 27576065
[TBL] [Abstract][Full Text] [Related]
6. Certification for biobanks: the program developed by the Canadian Tumour Repository Network (CTRNet).
Matzke EA; O'Donoghue S; Barnes RO; Daudt H; Cheah S; Suggitt A; Bartlett J; Damaraju S; Johnston R; Murphy L; Shepherd L; Mes-Masson AM; Schacter B; Watson PH
Biopreserv Biobank; 2012 Oct; 10(5):426-32. PubMed ID: 24845043
[TBL] [Abstract][Full Text] [Related]
7. Toward a Synergistic Operating Model for Westmead Research Hub Biobanks: A Questionnaire Study.
St George G; Wang XM; Linton J; Douglas N; Carpenter JE; Clarke CL; Heads JA
Biopreserv Biobank; 2019 Dec; 17(6):570-576. PubMed ID: 31429584
[TBL] [Abstract][Full Text] [Related]
8. The Biobank Economic Modeling Tool (BEMT): Online Financial Planning to Facilitate Biobank Sustainability.
Odeh H; Miranda L; Rao A; Vaught J; Greenman H; McLean J; Reed D; Memon S; Fombonne B; Guan P; Moore HM
Biopreserv Biobank; 2015 Dec; 13(6):421-9. PubMed ID: 26697911
[TBL] [Abstract][Full Text] [Related]
9. A Biospecimen Proficiency Testing Program for Biobank Accreditation: Four Years of Experience.
Gaignaux A; Ashton G; Coppola D; De Souza Y; De Wilde A; Eliason J; Grizzle W; Guadagni F; Gunter E; Koppandi I; Shea K; Shi T; Stein JA; Sobel ME; Tybring G; Van den Eynden G; Betsou F
Biopreserv Biobank; 2016 Oct; 14(5):429-439. PubMed ID: 27195612
[TBL] [Abstract][Full Text] [Related]
10. Biobank networking and globalisation: perspectives and practices of Australian biobanks.
Light E; Wiersma M; Dive L; Kerridge I; Lipworth W; Stewart C; Kowal E; Marlton P; Critchley C
Aust Health Rev; 2021 Mar; 45(2):214-222. PubMed ID: 33212000
[TBL] [Abstract][Full Text] [Related]
11. Nordic biological specimen bank cohorts as basis for studies of cancer causes and control: quality control tools for study cohorts with more than two million sample donors and 130,000 prospective cancers.
Pukkala E
Methods Mol Biol; 2011; 675():61-112. PubMed ID: 20949384
[TBL] [Abstract][Full Text] [Related]
12. Traditional and electronic informed consent for biobanking: a survey of U.S. biobanks.
Simon CM; Klein DW; Schartz HA
Biopreserv Biobank; 2014 Dec; 12(6):423-9. PubMed ID: 25496155
[TBL] [Abstract][Full Text] [Related]
13. Current practices for access, compensation, and prioritization in biobanks. Results from an interview study.
Langhof H; Kahrass H; Illig T; Jahns R; Strech D
Eur J Hum Genet; 2018 Nov; 26(11):1572-1581. PubMed ID: 30089824
[TBL] [Abstract][Full Text] [Related]
14. Defining biobank.
Hewitt R; Watson P
Biopreserv Biobank; 2013 Oct; 11(5):309-15. PubMed ID: 24835262
[TBL] [Abstract][Full Text] [Related]
15. A practical tool for modeling biospecimen user fees.
Matzke L; Dee S; Bartlett J; Damaraju S; Graham K; Johnston R; Mes-Masson AM; Murphy L; Shepherd L; Schacter B; Watson PH
Biopreserv Biobank; 2014 Aug; 12(4):234-9. PubMed ID: 25162459
[TBL] [Abstract][Full Text] [Related]
16. Biobank Continuity Management: A Survey of Biobank Professionals.
Church TD; Richmond FJ
Biopreserv Biobank; 2019 Oct; 17(5):410-417. PubMed ID: 31017454
[TBL] [Abstract][Full Text] [Related]
17. Construction of a business model to assure financial sustainability of biobanks.
Warth R; Perren A
Biopreserv Biobank; 2014 Dec; 12(6):389-94. PubMed ID: 25496150
[TBL] [Abstract][Full Text] [Related]
18. Critical Financial Challenges for Biobanking: Report of a National Cancer Institute Study.
Rao A; Vaught J; Tulskie B; Olson D; Odeh H; McLean J; Moore HM
Biopreserv Biobank; 2019 Apr; 17(2):129-138. PubMed ID: 30638412
[TBL] [Abstract][Full Text] [Related]
19. A proposed schema for classifying human research biobanks.
Watson PH; Barnes RO
Biopreserv Biobank; 2011 Dec; 9(4):327-33. PubMed ID: 24836628
[TBL] [Abstract][Full Text] [Related]
20. The ISBER Self-Assessment Tool Indicates Main Pathways for Improvement in Biobanks and Supports International Standardization.
Betsou F
Biopreserv Biobank; 2018 Feb; 16(1):7-8. PubMed ID: 29359960
[No Abstract] [Full Text] [Related]
[Next] [New Search]
